Inclusion of medicines with Risk Minimisation Measures (RMM) in Patient Group Directions (PGDs)

This Q&A, developed with MHRA, highlights that use of a medicine with RMM for close monitoring and supervision of patients may not be suitable for inclusion in a PGD. If a decision is taken to include such a medicine in a PGD, the requirements of the RMM must be included in PGD.

Specialist Pharmacy Service